Read more at: T-Therapeutics: reshaping the clinical landscape for cancer patients
T-Therapeutics: reshaping the clinical landscape for cancer patients
16 October 2025
Built on the foundations of research from Professor Allan Bradley in the University’s Department of Medicine, T-Therapeutics ’ OpTiMus® platform sidesteps shortfalls in immuno-oncology by creating a near-unlimited database of optimal T cell receptors (TCRs). These TCRs are used as building blocks for new therapies to...